CLADQoL: CLADribine tablets –evaluation of Quality of Life - CLADQoL
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2019
Price : $35 *
At a glance
- Drugs Cladribine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms CLADQoL
- Sponsors Merck Serono
- 28 Aug 2019 According to an Merck & Co Media release, data from this study will be presented at the 35th Congress of the European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS).
- 01 Oct 2018 Status changed from not yet recruiting to recruiting.
- 22 Jun 2018 New trial record